Decreased expression of Bid in human hepatocellular carcinoma is related to hepatitis B virus X protein (Q45735865)

15 December 2017

title

Decreased expression of Bid in human hepatocellular carcinoma is related to hepatitis B virus X protein (English)

1 reference

15 December 2017

1 reference

hepatocellular carcinoma

1 reference

2

1 reference

15 December 2017

3

1 reference

15 December 2017

Chen GG

1

1 reference

15 December 2017

Chak EC

4

1 reference

15 December 2017

Yip JH

5

1 reference

15 December 2017

Ho RL

6

1 reference

15 December 2017

Leung BC

7

1 reference

15 December 2017

Lau WY

8

1 reference

15 December 2017

publication date

1 September 2001

1 reference

European Journal of Cancer

15 December 2017

published in

1 reference

15 December 2017

volume

37

1 reference

15 December 2017

issue

13

1 reference

15 December 2017

page(s)

1695-1702

1 reference

The Bcl-2 protein family: arbiters of cell survival

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

Solution structure of BID, an intracellular amplifier of apoptotic signaling

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

The pro-apoptotic proteins, Bid and Bax, cause a limited permeabilization of the mitochondrial outer membrane that is enhanced by cytosol

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

The Destabilization of Lipid Membranes Induced by the C-terminal Fragment of Caspase 8-cleaved Bid Is Inhibited by the N-terminal Fragment

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

The hepatitis B virus HBx protein inhibits caspase 3 activity.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

Hepatitis B virus X protein inhibits transforming growth factor-beta -induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

Direct association and nuclear import of the hepatitis B virus X protein with the NF-kappaB inhibitor IkappaBalpha

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

Expression of Fas-related genes in human hepatocellular carcinomas.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

Fas and Fas ligand: strong co-expression in human hepatocytes surrounding hepatocellular carcinoma; can cancer induce suicide in peritumoural cells?

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

The gene for death agonist BID maps to the region of human 22q11.2 duplicated in cat eye syndrome chromosomes and to mouse chromosome 6.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

Lethal effect of the anti-Fas antibody in mice

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

In vivo expression of soluble Fas and FAP-1: possible mechanisms of Fas resistance in human hepatoblastomas

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

Gene cloning, RNA distribution, and functional expression of mCX3CR1, a mouse chemotactic receptor for the CX3C chemokine fractalkine

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

Immunohistochemical studies of intrahepatic tumour necrosis factor alpha in chronic liver disease

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

A1 functions at the mitochondria to delay endothelial apoptosis in response to tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

Differentiation status modulates transcription factor NF-kappaB activity in unstimulated human hepatocellular carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

Trans-activation of cellular genes by hepatitis B virus proteins: a possible mechanism of hepatocarcinogenesis.

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

In vitro transformation by hepatitis B virus DNA

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

Hepatitis B virus HBx gene and hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(01)00182-4

7 January 2021

10.1016/S0959-8049(01)00182-4

Identifiers

DOI

1 reference

15 December 2017

1 reference